WHO panel on traditional medicine has endorsed a protocol for phase III clinical trials of African herbal medicines for COVID-19.
“If a traditional medicine product is found to be safe, efficacious and quality-assured, WHO will recommend for a fast-tracked, large-scale local manufacturing,” Dr Prosper Tumusiime, Director of Universal Health Coverage and Life Course Cluster at WHO Regional Office for Africa said.
WHO official said that phase III clinical trials are pivotal in fully assessing the safety
“Just like other areas of medicine, sound science is the sole basis for safe and effective traditional medicine therapies. The onset of COVID-19, like the Ebola outbreak in West Africa, has highlighted the need for strengthened health systems and accelerated research and development programs, including on traditional medicines,” Dr Tumusiime said.